Literature DB >> 29998977

The histopathology of myeloma in the bone marrow.

Masahiko Fujino.   

Abstract

Myeloma is characterized by the neoplastic proliferation of monoclonal plasma cells. A diagnosis of myeloma is based on the criteria proposed by the International Myeloma Working Group and the pathological findings.Myeloma cells are classified into four types: mature, immature, pleomorphic, and plasmablastic. There are three patterns in which myeloma infiltrates bone marrow - nodular, interstitial, and diffuse. Dutcher bodies are highly specific to neoplastic myeloma cells. On immunohistochemical staining, the specificity of CD138 is high for plasma cells. As a clear image is often not obtained from the immunohistochemical staining of the immunoglobulin light chain, in situ hybridization is recommended. Abnormal expression of CD56 is seen in 70-80% of cases by flow cytometry analysis. CD56 expression definitively indicates myeloma, suggesting its high diagnostic value. Evaluation of the infiltration pattern, monoclonality, and abnormal antigen expression of plasma cells is more important than the plasmocytic ratio to determine whether a case is reactive or neoplastic.Multiple gene abnormalities function in the onset and progression of myeloma. In our department, we analyze CCND1, FGFR3, MAF, and del (17p13) by FISH for all myeloma cases. None of the cases with genetic abnormalities were recognized by G-banding. Therefore, FISH is more effective than G-banding for the evaluation of genetic abnormalities in myeloma.

Entities:  

Keywords:  Bone marrow; FISH method; Genetic abnormality; Myeloma; Pathological finding

Mesh:

Year:  2018        PMID: 29998977      PMCID: PMC6413148          DOI: 10.3960/jslrt.18014

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  2 in total

Review 1.  Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.

Authors:  Megan J Fitzpatrick; Valentina Nardi; Aliyah R Sohani
Journal:  Skeletal Radiol       Date:  2021-03-09       Impact factor: 2.199

2.  Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.

Authors:  Libere J Ndacayisaba; Kate E Rappard; Stephanie N Shishido; Carmen Ruiz Velasco; Nicholas Matsumoto; Rafael Navarez; Guilin Tang; Pei Lin; Sonia M Setayesh; Amin Naghdloo; Ching-Ju Hsu; Carlisle Maney; David Symer; Kelly Bethel; Kevin Kelly; Akil Merchant; Robert Orlowski; James Hicks; Jeremy Mason; Elisabeth E Manasanch; Peter Kuhn
Journal:  Curr Oncol       Date:  2022-04-21       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.